42 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
3 Unknown  Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
Conditions: Pancreatic Tumor;   Gastric Tumor;   Esophageal Tumor;   Lymphadenopathy;   Duodenal Tumor
Intervention: Procedure: Endoscopic ultrasound guided needle tissue acquisition.
4 Unknown  Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
Condition: Peptic Ulcer Hemorrhage
Interventions: Other: Empirical  Hp eradication;   Other: Eradication treatment guided by a positive test
5 Recruiting Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding
Condition: Bleeding Peptic Ulcers
Intervention: Device: Hemospray Kit
6 Recruiting Early Selective Transarterial Embolization (TAE) to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis
Conditions: Bleeding;   Peptic Ulcer;   Arterial Embolization
Interventions: Procedure: TAE;   Procedure: No TAE
7 Recruiting H2RA VS PPI for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk
Condition: Peptic Ulcer Bleeding
Interventions: Drug: Rabeprazole;   Drug: Famotidine
8 Not yet recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
9 Recruiting Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication
Conditions: Dyspepsia;   Peptic Ulcer
Interventions: Drug: Lansoprazole;   Drug: Bismuth Potassium Citrate;   Drug: Amoxicillin;   Drug: Metronidazole;   Drug: Clarithromycin
10 Unknown  Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
Conditions: Peptic Ulcer;   Ulcer Complications
Interventions: Drug: lansoprazole;   Drug: aluminum hydroxide 334 mg and Mg hydroxide 166 mg
11 Recruiting Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding
Condition: Active Peptic Ulcer Disease/GI Bleeding
Interventions: Device: epinephrine injection plus soft coagulation using hemostatic forceps;   Device: epinephrine injection plus argon plasma coagulation
12 Not yet recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
13 Unknown  Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy
Condition: Bleeding Peptic Ulcer
Intervention: Device: Endoscopic placement of Capsule endoscope adjacent to the peptic ulcer
14 Unknown  High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
Conditions: Endoscopy;   Peptic Ulcer;   Bleeding;   Proton Pump Inhibitors
Interventions: Drug: High dose pantoprazole infusion;   Drug: Standard dose pantoprazole infusion
15 Unknown  Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Bile Duct Neoplasms;   Ampullary Neoplasms;   Duodenal Neoplasms;   Pancreatitis
Interventions: Procedure: Billroth-II-type reconstruction;   Procedure: Isolated Roux-en-Y type reconstruction
16 Unknown  Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis
Condition: Peptic Ulcers
Interventions: Drug: Pantoprazole (Pantoloc);   Drug: Lansoprazole (Takepron OD)
17 Unknown  Cytokine Gene Polymorphisms in Gastric Diseases
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Cancer
Intervention: Procedure: IL-1, TNF-alpha, Il-10
18 Recruiting The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding and the Selection Criteria for Second-look Endoscopy for Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Bleeding
Intervention: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden)
19 Recruiting Adverse Events During Upper Gastrointestinal Endoscopy
Conditions: Patients Need Upper Gastrointestinal Endoscopy;   Peptic Ulcer;   Gastric Cancer;   Esophagus Cancer;   Oesophagitis
Intervention:
20 Unknown  Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
Condition: Peptic Ulcer
Intervention: Drug: esomeprazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years